North York, Canada

Hong Cui

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nono Inc.. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Cui. Retrieved from https://idiyas.com/inventor/hong-cui-gl7qg49j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Hong Cui: Pioneering Advances in Pharmacologic Delivery Systems

Introduction

Hong Cui, based in North York, Canada, is a distinguished inventor known for his contributions to pharmaceutical innovation. With three patents to his name, Cui has made significant strides in methods that enhance the delivery of pharmacologic agents, particularly in the realm of anti-inflammatory applications.

Latest Patents

One of Hong Cui's latest inventions focuses on the co-administration of an agent linked to an internalization peptide with an anti-inflammatory. This invention provides novel methods of delivering pharmacologic agents linked to internalization peptides while mitigating the inflammatory response that may arise from their use. The methods, as elaborated in his patent, highlight how an inflammatory response following the administration of a pharmacological agent can be effectively inhibited through the co-administration of an anti-inflammatory or by linking the internalization peptide to biotin or similar molecules. This approach is especially relevant for high-dosage applications, where mast cell degranulation and histamine release could lead to problematic side effects like redness, heat, swelling, and hypotension.

Career Highlights

Cui’s work has established him as a prominent figure in the field of pharmacology. As an inventor at Nono Inc., his ongoing contributions have the potential to transform treatment methodologies and enhance patient care through improved pharmacologic delivery systems. His dedication to research and innovation underscores his commitment to advancing medical science.

Collaborations

Throughout his career, Hong Cui has collaborated with notable colleagues, including Michael Tymianski and Jonathan David Garman. These partnerships have fostered a collaborative environment that fuels creativity and innovation, paving the way for significant advancements in their respective fields.

Conclusion

In summary, Hong Cui's innovative approach to pharmacologic agent delivery exemplifies the impact of scientific research on medicine. His patents not only highlight his inventive capabilities but also serve as a testament to the importance of collaboration in driving forward-thinking solutions in healthcare. As he continues his work at Nono Inc., the medical community eagerly anticipates the future developments that will arise from his research and innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…